APA (7th ed.) Citation

M, F., M, S., K, M., A, H., MC, V., A, D., . . . J, M. (2023). Adaptive nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication. Journal of medical genetics, 60(12), 1206. https://doi.org/10.1136/jmg-2023-109155

Chicago Style (17th ed.) Citation

M, Filser, et al. "Adaptive Nanopore Sequencing to Determine Pathogenicity of BRCA1 Exonic Duplication." Journal of Medical Genetics 60, no. 12 (2023): 1206. https://doi.org/10.1136/jmg-2023-109155.

MLA (9th ed.) Citation

M, Filser, et al. "Adaptive Nanopore Sequencing to Determine Pathogenicity of BRCA1 Exonic Duplication." Journal of Medical Genetics, vol. 60, no. 12, 2023, p. 1206, https://doi.org/10.1136/jmg-2023-109155.